AQP5 and chronic myelogenous leukemia, BCR-ABL1 positive: Accordingly, we have further examined whether AQP5 expression in CML cells is linked with bcr-abl amplification, or mutation, or secondary chromosomal changes other than t(9,22) in imatinib mesylate resistant CML cases.